Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
214 hedge funds and large institutions have $2.77B invested in Cantel Medical Corporation in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 87 increasing their positions, 65 reducing their positions, and 25 closing their positions.
34% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 65
22% more call options, than puts
Call options by funds: $1.52M | Put options by funds: $1.25M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less capital invested
Capital invested by funds: $2.82B → $2.77B (-$51.4M)
4% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 25
2% less funds holding
Funds holding: 218 → 214 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$21.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$11.3M |
| 3 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
+$10.4M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$10.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$24.7M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$11.5M |
| 3 |
Cerity Partners
New York
|
-$11.2M |
| 4 |
KB
Kimelman & Baird
New York
|
-$9.35M |
| 5 |
O
OppenheimerFunds
New York
|
-$6M |
CMD Hedge Fund Activity: Q2 2017 in Review
214 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2017, worth a combined $2.77B — down 1.8% from $2.82B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of CMD and 24 opened new positions — a net loss of 1 holder — while 65 trimmed existing stakes and 87 added.
The largest buyer was Ranger Investment Management, adding an estimated $21.1M. The largest seller was BlackRock, cutting an estimated $24.7M.
- 214 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2017, down from 218 in Q1 2017.
- Funds reported $2.77B of Cantel Medical Corporation stock for Q2 2017, down 1.8% quarter-over-quarter.
- 24 funds opened new Cantel Medical Corporation positions in Q2 2017 and 25 closed out, a net change of -1 holder.
- The largest Cantel Medical Corporation buyer in Q2 2017 was Ranger Investment Management, an estimated $21.1M added.
- The largest Cantel Medical Corporation seller in Q2 2017 was BlackRock, an estimated $24.7M sold.
Based on aggregated 13F filings for Q2 2017.